News | September 14, 2011

GE Launches Company to Enhance Development of Innovative Imaging Technology

September 14, 2011 – To accelerate and enhance the development of metabolic imaging and other innovative technology, GE has launched a new entity, Research Circle Technology Inc. (RCT). RCT’s vision is to create a strong alliance between GE’s scientists and the world’s leading universities, providing easy access to GE’s organic technology and wide scope of healthcare expertise in an open innovation structure.

Already, global leaders of imaging technology and disease detection research have explored potential applications for metabolic imaging technology:

  • University of California – San Francisco’s Surbeck Laboratory for Advanced Imaging has announced the groundbreaking results of a study utilizing GE’s 13-C (Carbon 13) technology to study prostate cancer. “This is the first time researchers have used this technology to conduct real-time metabolic imaging in a human patient, and represents a revolutionary approach to assessing the precise outlines of a tumor, its response to treatment and how quickly it is growing,” said Sarah J. Nelson, Ph.D., a professor of radiology and biomedical imaging at UCSF. Nelson is presenting the team’s findings at the World Molecular Imaging Conference (WMIC) in San Diego this week.
  • Scientists at Cancer Research UK’s Cambridge Research Institute have developed a technique to show the effectiveness of breast cancer treatment weeks earlier than current methods through metabolic imaging. According to lead researcher Professor Kevin Brindle, “There has been a need to develop imaging methods that can help detect treatment response more accurately than traditional methods and before tumors change size. Our new imaging method not only shows early evidence that treatment is working but could also help predict the long-term outcome. We expect that these techniques will have an impact for patients in the near future.”

Through RCT, GE looks to continue developing this innovative technology, providing the tools, services and solutions so that leading researchers can focus on their investigations into the biochemistry of metabolism and speed the discovery of potentially lifesaving knowledge. RCT will sell SpinLab polarizers as well as provide the licensing framework for partners to continue to develop the metabolic imaging applications. RCT helps enable GE to fully connect with the skills and knowledge of the research community, with the goal of transitioning technology from ‘bench to bedside’ more efficiently.

“The focused goal of RCT is open collaboration to bring hyperpolarization technology to the worlds’ leading researchers and enable their studies to better understand the biochemistry of life,” said Jonathan A. Murray, managing director, RCT. “The early results are very exciting and we are delighted to collaborate with this community to help bring this innovative technology to its full potential.”

For more information:


Related Content

Videos | SPECT-CT | December 12, 2018
This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 ...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...